Chris Compton

830 total citations
46 papers, 460 citations indexed

About

Chris Compton is a scholar working on Pulmonary and Respiratory Medicine, Physiology and General Health Professions. According to data from OpenAlex, Chris Compton has authored 46 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 35 papers in Physiology and 2 papers in General Health Professions. Recurrent topics in Chris Compton's work include Chronic Obstructive Pulmonary Disease (COPD) Research (43 papers), Asthma and respiratory diseases (35 papers) and Respiratory Support and Mechanisms (15 papers). Chris Compton is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (43 papers), Asthma and respiratory diseases (35 papers) and Respiratory Support and Mechanisms (15 papers). Chris Compton collaborates with scholars based in United States, Canada and United Kingdom. Chris Compton's co-authors include David A. Lipson, David Halpin, Claus Vogelmeier, Ian Naya, Lee Tombs, Afisi Ismaila, Paul Jones, François Maltais, Leif Bjermer and MeiLan K. Han and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, BMJ Open and The Lancet Respiratory Medicine.

In The Last Decade

Chris Compton

37 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Compton United States 10 438 306 22 14 12 46 460
Alessandro Guasconi Italy 6 474 1.1× 357 1.2× 13 0.6× 17 1.2× 7 0.6× 23 493
H Prunier Italy 2 390 0.9× 299 1.0× 10 0.5× 15 1.1× 7 0.6× 4 399
Bettina Hederer Switzerland 7 611 1.4× 445 1.5× 19 0.9× 20 1.4× 14 1.2× 13 639
Ruby Birk United States 6 339 0.8× 258 0.8× 9 0.4× 13 0.9× 10 0.8× 14 349
M. Reza Maleki-Yazdi Canada 11 575 1.3× 464 1.5× 17 0.8× 7 0.5× 8 0.7× 21 610
Catherine Francisco Italy 4 610 1.4× 482 1.6× 7 0.3× 28 2.0× 8 0.7× 6 628
Chris Compton United States 11 333 0.8× 270 0.9× 7 0.3× 23 1.6× 6 0.5× 29 345
Sabine Kattenbeck Germany 5 382 0.9× 270 0.9× 8 0.4× 5 0.4× 13 1.1× 10 406
Kiernan DeAngelis United States 8 346 0.8× 255 0.8× 12 0.5× 11 0.8× 7 0.6× 17 360
Inge Leimer Germany 7 303 0.7× 194 0.6× 20 0.9× 5 0.4× 7 0.6× 12 328

Countries citing papers authored by Chris Compton

Since Specialization
Citations

This map shows the geographic impact of Chris Compton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Compton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Compton more than expected).

Fields of papers citing papers by Chris Compton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Compton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Compton. The network helps show where Chris Compton may publish in the future.

Co-authorship network of co-authors of Chris Compton

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Compton. A scholar is included among the top collaborators of Chris Compton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Compton. Chris Compton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yatera, Kazuhiro, Zhang Wang, Yoko Shibata, et al.. (2025). Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study. International Journal of COPD. Volume 20. 1477–1492.
2.
Aggarwal, Bhumika, Paul Jones, Alejandro Casas, et al.. (2024). Association between Increased Risk of Pneumonia with ICS in COPD: A Continuous Variable Analysis of Patient Factors from the IMPACT Study. Pulmonary Therapy. 10(2). 183–192. 6 indexed citations
3.
Vogelmeier, Claus, Kai Michael Beeh, Nils Kossack, et al.. (2024). Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study. International Journal of COPD. Volume 19. 1835–1848. 3 indexed citations
4.
5.
Vogelmeier, Claus, Kai Michael Beeh, Péter Kardos, et al.. (2024). Baseline patient demographics for TETRIS: a prospective, noninterventional study to characterize the use of triple therapy for COPD in Germany. Therapeutic Advances in Respiratory Disease. 18. 2693866949–2693866949.
6.
Rothnie, Kieran, Robert Wood, Victoria Banks, et al.. (2024). Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study. BMJ Open Respiratory Research. 11(1). e001890–e001890. 2 indexed citations
7.
8.
Haeussler, Katrin, Afisi Ismaila, Stephen G. Noorduyn, et al.. (2024). Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians. Respiratory Research. 25(1). 438–438. 1 indexed citations
9.
Beeh, Kai Michael, Kieran Rothnie, Jing Claussen, et al.. (2024). Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International Journal of COPD. Volume 19. 945–956. 1 indexed citations
10.
Mannino, David M., Stephen Weng, Guillaume Germain, et al.. (2024). Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease. Advances in Therapy. 42(2). 1131–1146. 3 indexed citations
11.
Rothnie, Kieran, Stephen G. Noorduyn, Jonathan C. Claussen, et al.. (2023). PCR255 Adherence to Single and Multiple Inhaled Triple Therapies in Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany, Considering Different Definitions. Value in Health. 26(12). S499–S499. 1 indexed citations
12.
13.
14.
15.
16.
17.
Halpin, David, Kieran Rothnie, Victoria Banks, et al.. (2022). Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. International Journal of COPD. Volume 17. 2417–2429. 31 indexed citations
18.
Halpin, David, Alan Martin, Dhvani Shah, et al.. (2022). Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial. International Journal of COPD. Volume 17. 2745–2755. 10 indexed citations
19.
20.
Pascoe, Steven, Neil Barnes, Guy Brusselle, et al.. (2019). Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial. The Lancet Respiratory Medicine. 7(9). 745–756. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandro Guasconi Breakdown of academic impact, for papers by H Prunier Breakdown of academic impact, for papers by Bettina Hederer Breakdown of academic impact, for papers by Ruby Birk Breakdown of academic impact, for papers by M. Reza Maleki-Yazdi Breakdown of academic impact, for papers by Catherine Francisco Breakdown of academic impact, for papers by Chris Compton Breakdown of academic impact, for papers by Sabine Kattenbeck Breakdown of academic impact, for papers by Kiernan DeAngelis Breakdown of academic impact, for papers by Inge Leimer
Rankless by CCL
2026